Recent ABCL News
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/06/2024 08:55:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/06/2024 08:26:59 PM
- AbCellera Reports Q2 2024 Business Results • Business Wire • 08/06/2024 08:05:00 PM
- AbCellera and Lilly Expand Collaboration to Develop Antibody Medicines • Business Wire • 07/31/2024 01:00:00 PM
- AbCellera to Report Second Quarter 2024 Financial Results on August 6, 2024 • Business Wire • 06/25/2024 08:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/13/2024 08:53:28 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/03/2024 08:21:18 PM
- AbCellera to Present at the Goldman Sachs 45th Annual Global Healthcare Conference on June 10, 2024 • Business Wire • 05/28/2024 08:05:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/07/2024 08:47:59 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/07/2024 08:22:22 PM
- AbCellera Reports Q1 2024 Business Results • Business Wire • 05/07/2024 08:05:00 PM
- AbCellera, Viking Global Investors, and ArrowMark Partners Collaborate to Launch New Biotech Companies • Business Wire • 05/01/2024 01:00:00 PM
- AbCellera Presents Data on T-Cell Engagers Against Four Tumor Targets at AACR 2024 • Business Wire • 04/08/2024 04:05:00 PM
- AbCellera to Report First Quarter 2024 Financial Results on May 7, 2024 • Business Wire • 04/03/2024 08:05:00 PM
- AbCellera to Present at the Bloom Burton Healthcare Conference on April 16, 2024 • Business Wire • 03/19/2024 08:05:00 PM
- AbCellera to Collaborate with Biogen to Discover Therapeutic Antibodies for Neurological Conditions • Business Wire • 03/11/2024 01:00:00 PM
- AbCellera Announces Four Presentations on T-Cell Engagers at AACR 2024 • Business Wire • 03/05/2024 09:30:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/27/2024 07:12:58 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/23/2024 09:49:40 PM
- AbCellera Announces Resignation of Board Member • Business Wire • 02/23/2024 09:30:00 PM
- AbCellera to Present at Upcoming Investor Conferences in March • Business Wire • 02/23/2024 01:15:00 AM
- Form S-8 - Securities to be offered to employees in employee benefit plans • Edgar (US Regulatory) • 02/20/2024 09:49:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/20/2024 09:27:58 PM
- AbCellera Reports Full Year 2023 Business Results • Business Wire • 02/20/2024 09:05:00 PM
- AbCellera to Report Full Year 2023 Financial Results on February 20, 2024 • Business Wire • 01/23/2024 09:05:00 PM
HealthLynked Corp. Announces Second Quarter and First Half 2024 Results: Continued Cost Reductions Set the Stage for Strategic Shift to App-Based Technology Services • HLYK • Aug 16, 2024 8:00 AM
PickleJar Announces Official Name Change and New Ticker Symbol • NREG • Aug 15, 2024 2:23 PM
VAYK's Q2 Profit Added to Accumulated Net Profit of Over $2.2 Million In 18 Months • VAYK • Aug 15, 2024 9:07 AM
Swifty Global Reports Strong Q2 Performance and Prepares for Major Exchange Uplisting • DRCR • Aug 15, 2024 9:04 AM
Mayback's Global Entertainment Signs Global Distribution Agreement with Children's Media Studio • AHRO • Aug 15, 2024 8:45 AM
POET Technologies Reports Second Quarter 2024 Financial Results • POET • Aug 15, 2024 8:04 AM